Nonoperating Income (Expense) in USD of Barinthus Biotherapeutics plc. from Q1 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Barinthus Biotherapeutics plc. quarterly/annual Nonoperating Income (Expense) history and change rate from Q1 2020 to Q3 2025.
  • Barinthus Biotherapeutics plc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $424K, a 66% decline year-over-year.
  • Barinthus Biotherapeutics plc. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $6.32M, a 8.59% increase year-over-year.
  • Barinthus Biotherapeutics plc. annual Nonoperating Income (Expense) for 2024 was $6.74M, a 8.78% decline from 2023.
  • Barinthus Biotherapeutics plc. annual Nonoperating Income (Expense) for 2023 was $7.39M, a 51.1% increase from 2022.
  • Barinthus Biotherapeutics plc. annual Nonoperating Income (Expense) for 2022 was $4.89M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

Barinthus Biotherapeutics plc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $6.32M $424K -$824K -66% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 $7.14M $2.17M +$837K +62.7% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $6.31M $920K -$437K -32.2% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025
Q4 2024 $6.74M $2.8M +$924K +49.2% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025
Q3 2024 $5.82M $1.25M -$144K -10.3% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025
Q2 2024 $5.96M $1.34M -$41K -2.98% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 $6M $1.36M -$1.39M -50.6% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025
Q4 2023 $7.39M $1.88M -$106K -5.34% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025
Q3 2023 $7.5M $1.39M +$1.08M +348% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 $6.42M $1.38M -$162K -10.5% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $6.58M $2.75M +$1.69M +160% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 $4.89M $1.98M +$455K +29.8% 01 Oct 2022 31 Dec 2022 10-K 20 Mar 2024
Q3 2022 $4.44M $311K -$648K -67.6% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $5.08M $1.54M +$667K +76.5% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 $4.42M $1.06M +$10.3M 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 -$5.92M $1.53M +$2.33M 01 Oct 2021 31 Dec 2021 10-K 24 Mar 2023
Q3 2021 -$8.25M $959K -$669K -41.1% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$7.58M $872K +$193K +28.4% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 -$7.77M -$9.28M -$9.98M -1429% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q4 2020 $2.21M -$797K 01 Oct 2020 31 Dec 2020 10-K 25 Mar 2022
Q3 2020 $1.63M 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 $679K 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 $698K 01 Jan 2020 31 Mar 2020 10-Q 14 Jun 2021

Barinthus Biotherapeutics plc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $6.74M -$649K -8.78% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025
2023 $7.39M +$2.5M +51.1% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025
2022 $4.89M +$10.8M 01 Jan 2022 31 Dec 2022 10-K 20 Mar 2024
2021 -$5.92M -$8.13M -368% 01 Jan 2021 31 Dec 2021 10-K 24 Mar 2023
2020 $2.21M 01 Jan 2020 31 Dec 2020 10-K 25 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.